The FDA's New Nicotine Pouch Guidance Explained

The FDA just made one of the biggest nicotine pouch announcements in years. Not because it approved new products (it didn’t). And not because products suddenly became legal nationwide overnight. They didn’t. 

What changed is how the FDA may approach enforcement while certain nicotine pouch products remain under scientific review. In simple terms, enforcement refers to which products and companies the FDA chooses to focus its regulatory actions on. 

For adult consumers, this could eventually lead to more nicotine pouch options becoming available over time. But the category remains heavily regulated, and FDA authorization is never guaranteed. 

On May 8, 2026, the FDA released new guidance covering certain nicotine pouch and e-cigarette products with pending PMTAs.

A PMTA (or Pre-Market Tobacco Application) is a very detailed scientific review process manufacturers must complete before products can receive FDA marketing authorization. Nothing has changed with that process and manufacturers still need to submit PMTAs. Products still undergo FDA scientific review. And products remain unauthorized unless the FDA formally grants marketing authorization. 

The FDA updated how it may prioritize enforcement while some PMTA reviews continue. Under the guidance, the agency says it does not intend to prioritize enforcement against certain unauthorized nicotine pouch products if manufacturers have: 

• A PMTA that has been accepted and filed; or 
• A pending and accepted supplemental PMTA. 

In practice, some products with active FDA applications may now be treated as lower enforcement priorities during review. That is not the same as approval or authorization. The FDA can still take enforcement action at any time. 

For years, uncertainty around enforcement has shaped the nicotine pouch category. This announcement gives manufacturers, retailers, and adult consumers a clearer sense of how the FDA may approach the market moving forward. 

According to the guidance, the FDA plans to focus enforcement more heavily on manufacturers that: 

• Never submitted a PMTA; 
• Had applications refused or rejected; 
• Withdrew applications; 
• Sell counterfeit products; or 
• Misdeclare products at U.S. Customs. 

The FDA also plans to release a public list of products covered under its current enforcement policy. That list could become an important reference point as the market continues evolving. 

Over time, adult consumers may begin seeing more nicotine pouch products become available online and in stores. 

That could include: 

• Additional flavors; 
• More nicotine strengths; 
• New pouch formats and sizes; and 
• Products from manufacturers already familiar to adult consumers. 

But changes are expected to happen gradually and not every product will be available in every state. The availability will still depend on factors like state restrictions, FDA enforcement status, manufacturer compliance, and our own review process. 

Federal guidance is only one part of the regulatory landscape. Many states continue to maintain their own nicotine product registration systems, flavor restrictions, and product requirements. As a result, customers in different states may continue seeing different product selections even if federal enforcement priorities shift. 

Our standards are not changing. Responsible retailing remains central to how we operate. 

That includes: 

• Third-party quality testing; 
• Strict age and identity verification requirements; 
• Ongoing compliance review for marketing and communications; and 
• Continued monitoring of federal, state, and local regulations. 

This is a significant regulatory development for the nicotine pouch category. But it is not a shortcut around FDA authorization. The PMTA process remains lengthy. Scientific review still matters. And the FDA has not guaranteed authorization for any product covered by the guidance. 

Still, many across the industry see this as an important signal for how the market may continue evolving in the months ahead. We’ll continue monitoring developments and sharing updates as more information becomes available.